Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation (Sazawal S et al. Indian J Cancer, July - Sept 2020)

Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation
Sazawal S et al. Indian J Cancer, July – Sept 2020 – open access publication

Link to full abstract

 


 

Outcomes of children with chronic myeloid leukemia: A population-based cohort study (Egan G et al. Pediatr Blood Cancer, July 2020)

Outcomes of children with chronic myeloid leukemia: A population-based cohort study
Egan G et al. Pediatr Blood Cancer, July 2020

Link to full abstract

 


 

BCR-ABL tyrosine kinase inhibitors in the treatment of pediatric CML (Carafiglio F et al. Int J Mol Sci, June 2020)

BCR-ABL tyrosine kinase inhibitors in the treatment of pediatric CML
Carofiglio F et al. Int J Mol Sci, June 2020 - open access publication

Link to full abstract

 


 

Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation and the effects on growth in a child with CML: not always a short story (Triche L et al. Pediatr Hematol, Oncol, August 2020)

Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation and the effects on growth in a child with CML: not always a short story
Triche L et al. Pediatr Hematol Oncol, August 2020 – open access publication 

Link to full abstract

 


 

Ponatinib in childhood Philadelphia chromosome-positive leukemias: an International registry of childhood chronic myeloid leukemia study (Millot F et al. Eur J Cancer, July 2020)

Ponatinib in childhood Philadelphia chromosome-positive leukemias: an International registry of childhood chronic myeloid leukemia study
Millot F et al. Eur J Cancer, July 2020

Link to full abstract

 


 

  1. Imatinib-induced hypogammaglobulinemia in children and adolescents with chronic myeloid leukemia
  2. Vaccination with live attenuated vaccines in four children with chronic myeloid leukemia while on imatinib treatment
  3. Experience with ponatinib in paediatric patients with leukaemia
  4. Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukemia